# TREATMENT ADHERENCE BY BIPOLAR DISORDER PATIENTS

of patient-reported nonadherence equivalent to major defaulting on 20-30% of days would be needed to accord with comparable nonadherence estimates of 69 of patients made by their physicians (Table 2). These self-reports of incomplete adherence with prescribed treatments for BPD in one-third of patients are unverified; but the risk of under-reporting may be limited by the very sensitive standard applied in an effort to detect the worst case for incomplete treatment-adherence. In addition to the self-reported recent incomplete treatment-adherence just noted, 32.9% [137/417] of patients also reported having discontinued all recommended medications for BPD at some point in the past, without informing their physicians. Leading reasons given for such patient-initiated discontinuation of treatment, among 130 patients providing such information, ranked: a) not needing it any longer (22.39) > (b) no longer wanting to take it (18.59) > (c) side effects (13.1%) > (d) feeling better at the time (10.89).

The rate of reported major defaulting in the past (32.99), and the rate of missing recent single doses (33.89), is similar; and many cases of previous and current nonadherence (45.0%) involved the same persons. Both rates represent about one-third of all treated patients with BPD sampled, indicating that some degree of treatment-nonadherence may be quite prevalent among contemporary American BPD patients. The apparently large disparity between physicians' impressions and patient self-reports is noteworthy; but may reflect differences in definitions of "nonadherence," such that physicians' self-defined nonadherence was likely to reflect clinically important levels of missed dosing periods of risk; whereas patients were asked about even single missed doses within 10 recent days.

# Table 3 Major frustrations reported by BPD patients

|Characteristic|Count (%)|
|---|---|
|Illness-related factors| |
|Mood swings|281 (66.4)|
|Depressions|238 (56.3)|
|Others' perceptions/stigma|184 (43.5)|
|Problems with trust/relationships/social interactions|171 (40.4)|
|Holding down a job|152 (35.9)|
|Hospitalization|118 (27.9)|
|Highs of mood|115 (27.2)|
|Lack of information|26 (6.15)|
|Treatment-related factors| |
|Taking medication every day|216 (51.1)|
|Medication side-effects|170 (40.2)|
|Cost of treatment|3 (0.71)|
|Miscellaneous factors| |
|Other|34 (8.04)|

Responding patients (N = 423; 98.69 cited four major frustrations/person (1708/423).

# Physician assessments of treatment

When psychiatrists were asked to report improvements in treatments for BPD patients needed to increase acceptance and adherence to treatment; the most common response was the need for better mood-stabilization in 48.0% of their 429 patients. In addition, they identified freedom from weight-gain as important for treatment-acceptance among 29.19% of their patients, and improvement of treatment-unresponsive depression in 30.8%. They also estimated that at least 59.0% of their BPD patients had experienced adverse effects of psychotropic medications at some time in the past, that adverse effects were of current concern to 14.0% of patients (60/429), and were considered by their physicians to be severe in 15.09% (9/60) of that subgroup. Psychiatrists reported further that 30.5% of their 429 BPD patients had experienced weight-gain in association with current treatment, with substantial prevalence of hyperlipidemia (19.1%) and diabetes (8.629) and identified these as problems of particular clinical concern.

# Univariate analyses of factors associated with treatment-nonadherence

We compared treatment-nonadherent with treatment-adherent patients on a list of factors identified in the PSF and PRF questionnaires, which yielded a total of 59 variables tentatively related to treatment adherence, based on initial univariate comparisons (p < 0.10), and 43 significantly (p < 0.05) associated.

Copyright 2007 John Wiley Sons, Ltd. Hum. Psychopharmacol Clin Exp 2008; 23: 95-105. DOI: 10.1002/hup